Australia markets open in 2 hours

Orgenesis Inc. (ORGS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7000+0.1400 (+3.07%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.5600
Open4.5800
Bid4.6200 x 1000
Ask4.6700 x 800
Day's range4.5800 - 4.7000
52-week range4.1400 - 8.3000
Volume15,522
Avg. volume48,815
Market cap114.094M
Beta (5Y monthly)1.22
PE ratio (TTM)N/A
EPS (TTM)-2.1720
Earnings date03 Nov 2021 - 08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.00
  • GlobeNewswire

    Orgenesis Announces Collaboration Agreement with Savicell to License and Deploy its ImmunoBiopsy™ Platform

    Goal to accelerate development, QC testing and manufacturing of Orgenesis’ cell and gene therapy platform New assays being developed to potentially enhance the potency of cell and gene therapies for use within POCare platform Plan to develop companion diagnostics to enhance targeting of cell and gene therapies GERMANTOWN, Md., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and g

  • GlobeNewswire

    Orgenesis Second Quarter 2021 Revenue Increases Over Six-Fold to $10.5 Million Compared to Second Quarter 2020 Reflecting Continued Progress of POCare Platform

    Orgenesis to host conference call today at 8:30AM ETGERMANTOWN, Md., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today reported financial results for the second quarter ended June 30, 2021. Vered Caplan, CEO of Orgenesis, stated, “I am pleased to report that our POCare revenues for the second quarter of 2021 increased more than six-fold to $10.5 million co

  • GlobeNewswire

    Orgenesis Schedules Second Quarter 2021 Business Update Conference Call

    GERMANTOWN, Md., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it plans to host a conference call at 8:30 AM Eastern Time on Thursday, August 5, 2021 to discuss the Company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 844-407-9500 for U.S. callers or for internation